Exploring Tofacitinib's Role in Psoriatic Disease Management

Wonder what choices are available for oral agents? Listen to a discussion of systemic nonbiologic therapies as addressed in the fifth "Guidelines of Care for the Management of Psoriasis" with preeminent dermatologist Dr. Kenneth Gordon, Professor and Chair of Dermatology at Froedtert and Medical College of Wisconsin in Milwaukee. The future of oral agents sounds promising! This guidelines activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.